Articles about 'GlaxoSmithKline (GSK)

The collaboration will use state-of-the-art genomics approaches in combination with machine learning methods to advance our scientific understanding of cells and tissues in health and disease.

Tammy Dougan on why it's so important that universities work with industry to get fundamental science out of the lab and into the real world.

Professor Duncan Richards has today been announced as the new Head of the Department of Medicine at the University of Cambridge.

The ambition of the partnership is to treat immune-related diseases more precisely with existing therapies and to rapidly develop new ones.

Apollo Therapeutics, a biopharmaceutical company originally set up by three UK universities (Cambridge, Imperial College London and University College London) and three pharmaceutical companies (AstraZeneca, GSK and Johnson & Johnson Innovation), has secured $226.5 million venture capital financing.

Cambridge's Experimental Medicine Initiative, working with AstraZeneca and GSK, is training specialists who can work out at an earlier stage of clinical trials if a treatment is likely to succeed.

Professor Steve Jackson talks about drug discovery, serial entrepreneurship and the enterprising mindset.

A potential new treatment to protect immunosuppressed patients from human cytomegalovirus (HCMV) has been discovered by scientists at the University of Cambridge. Their study shows that certain epigenetic inhibitors expose and help to destroy dormant HCMV infections, which often reactivate to cause serious illness and death in these vulnerable groups. Subject to clinical trials, their proposed ‘shock and kill’ treatment strategy offers hope to transplant patients across the world.

The Cambridge COVID-19 Testing Centre, set up in April in response to the urgent need to boost the UK’s testing capabilities, has processed two million tests.

They juggled their jobs and sacrificed sleep to volunteer at the Cambridge Testing Centre, a collaboration between the University, AstraZeneca and GSK to support the national effort to boost COVID-19 testing. They say they were simply fulfilling their duty as scientists. Meet the volunteers behind the masks.